GABAA Receptor and Memory Decline in Alzheimer's Mice
Author Information
Author(s): Yoshiike Yuji, Kimura Tetsuya, Yamashita Shunji, Furudate Hiroyuki, Mizoroki Tatsuya, Murayama Miyuki, Takashima Akihiko
Primary Institution: Laboratory for Alzheimer's Disease, RIKEN Brain Science Institute, Wako-shi, Saitama, Japan
Hypothesis
Enhanced GABAA receptor-mediated inhibition contributes to memory decline in APP/PS1 mice.
Conclusion
The study found that treating APP/PS1 mice with picrotoxin improved their memory deficits linked to GABAA receptor inhibition.
Supporting Evidence
- Adult APP/PS1 mice showed significant delays in reaching hidden platforms compared to nonTg mice.
- PTX treatment improved memory performance in APP/PS1 mice in both the Morris water maze and novel object recognition tests.
- Enhanced GABAA receptor-mediated inhibition was linked to reduced long-term potentiation in APP/PS1 mice.
Takeaway
Older mice with Alzheimer's have trouble remembering things, but a special medicine can help them remember better.
Methodology
The study used behavioral tests like the Morris water maze and novel object recognition to assess memory in APP/PS1 and nonTg mice, along with pharmacological treatment with picrotoxin.
Potential Biases
Potential bias due to the use of a single transgenic mouse line.
Limitations
The study was limited to male mice and did not explore long-term effects of picrotoxin treatment.
Participant Demographics
The study involved male APP/PS1 transgenic mice aged 9-15 months and old nonTg mice aged 19-25 months.
Statistical Information
P-Value
p=0.0003
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website